BCAX logo

BCAX Bicara Therapeutics

$16.56
$0.73
(4.22%)
Today
Closed $16.56
$0.00
(0.00%)
After Hours
48

Neutral Sentiment

How do you feel about BCAX?

Loading...

This is an ad slot. Start your free Edge trial and you won't see any ads for 30 days.

Ad free · Full sentiment data · Expanded watchers · Advanced search · No credit card required.

Advertisement|

Quantumup
Cantor reiterated $BCAX at Overweight and said -- We continue to believe that BCAX shares remain meaningfully undervalued given ficerafusp's potential to address the large and underserved HPV-negative HNSCC market. MRUS - $GMAB $JNJ PYXS MRK BMY LLY Cantor added—The company's $1B EV is well below the $8B GMAB (NC) paid for competitor MRUS last fall, and our $1.5B peak sales forecast in 1L R/M HPV-negative HNSCC supports severalfold upside from current levels. We believe growing anticipation of the mid-2027 Phase 3 interim results could drive continued share appreciation.
1